Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Jun 20, 2024 9:48am
169 Views
Post# 36097654

RE:RE:RE:RE:Now What?

RE:RE:RE:RE:Now What?
plantrader wrote: Of course we don't know if any bigger companies are interested in Theralase at all right now. And I assume it's possible that there might be firms looking at Theralase and saying:  Ehhh, they aren't at risk of getting anything to market any time soon so let's just watch and see if they run out of money. 

Meaning, the risk of doing nothing seems to be low from a 3rd party standpoint, doesn't it? The stock is lackadaisical, most of the company's work is preclinical and their sole PII trial is lacking the needed data for BTD (per the May 30th report) at this point. Let alone final FDA approval which also isn't near-term right now. And no mention of AA as a goal in quite some time now.

If they can get BTD and lock in substantial funding, maybe they will start to be taken more seriously.



Imo, the added validation that a BTD would provide should be the clincher that finally gets Pharma more seriously interested.  At that point, any "Ehhh" becomes an "Oh sh$t", if I continue to be ignorant or stay on the sidelines, my competitor can dive in for the kill & have the potential to corner a significant part of a many-billions dollar market!  IMO..
<< Previous
Bullboard Posts
Next >>